Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids
Clinical trial NCT04643158 · TERMINATED
Trial details
- NCT number
- NCT04643158
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2023-07-20
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.